US Patent 7169916 Chloral-free DCA in oligonucleotide synthesis
Patent 7169916 was granted and assigned to Ionis Pharmaceuticals on January, 2007 by the United States Patent and Trademark Office.
All edits
Edits on 6 Sep, 2023
Golden AI
Edits made to:
Infobox (+4 properties)
Infobox
Patent Inventor Names
Achim Krotz0
Brett Turney0
Daniel Capaldi0
Hans Gaus0
Edits on 31 Aug, 2023
Golden AI
Edits made to:
Article (+289 characters)
Article
Patent abstract
A process of manufacturing oligonucleotides includes a 5′-deblocking step in which the 5-blocking group is removed with dichloroacetic acid that is essentially free of chloral. The process is useful for making oligonucleotides that are substantially free of chloral adducts.
Edits on 14 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07169916 Chloral-free DCA in oligonucleotide synthesis US Patent 7169916 Chloral-free DCA in oligonucleotide synthesis
Infobox
Patent Number
07169916
Patent Number
7169916
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 8 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 20 Nov, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07169916 Chloral-free DCA in oligonucleotide synthesis
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07169916
Date of patent
January 30, 2007
Patent application number
10403692
Date Filed
March 31, 2003
Patent primary examiner
Find more entities like US Patent 7169916 Chloral-free DCA in oligonucleotide synthesis
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
